Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Analytical methods for screening new drug candidates More
A vector to be used for transfection and purification of human soluble FcRn receptor More
Screening compounds and model for the prevention of bone destruction More
Specific therapeutic target on platelets for blocking inflammatory diseases of the joint: “collagen microparticle footprint” More
This technology offers an alternative means to generate collagen and gelatin which are traditionally derived from animals including cows, pigs and also cadavers. More
We have developed a methodology for a chemically defined and effcient protocol which targets human embryonic stem cells towards a chondroprogenitor phenotype. More
Bio-mimicking (3D cell culture) research tools for drug development More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Aug 2011 - 8 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 8 pages - $75
Dec 2010 - 84 pages - $500
Nov 2011 - 8 pages - $75
Mar 2011 - 34 pages - $1,000
Jan 2006 - 21 pages - $1,100
Your selection
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Therapeutic target
- Age-related disorders (other)
- Back pain
- Birth defects
- Bone cancer
- Chronic granulomatous disease
- Dupuytren's disease
- Dyskinesia
- Fibrocystic breast disease
- Gout
- Growth disorders
- Hypomobility
- Intermittent claudication
- Leprosy
- Lupus erythematosis
- Muscular
- Musculoskeletal disorder (other)
- Scleroderma
- Sjogren's syndrome
- Skeletal
- Trauma, physical
- Wasting disease
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us